The FDA’s recent approval of 'Wegovy HD' is a troubling signal that we are moving toward a tiered system of human biology. This higher-dose metabolic drug offers greater weight loss to those who can afford the premium price tag, while the rest of the world is left with lower-dose generics. This bifurcation of the medical market treats the human body as a luxury commodity rather than a vessel of the soul. When health is sold as 'premium citizenship,' we have lost our way. True medicine should seek the healing of all, not the metabolic enhancement of the few who can pay for the 'high-definition' version of life.